6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cardiovascular disease (CVD) is the second leading cause of mortality worldwide, accounting for 17 million deaths in 2013. More than 80% of these cases were in low- and middle-income countries (LMICs). Although the risk factors for the development of CVD are similar throughout the world, the evolving change in lifestyle and health behaviours in LMICs-including tobacco use, decreased physical activity, and obesity-are contributing to the escalating presence of CVD and mortality. Although CVD mortality is falling in high-income settings because of more effective preventive and management programs, access to evidence-based interventions for combating CVD in resource-limited settings is variable. The existing pressures on both human and financial resources impact the efforts of controlling CVD. The implementation of emerging innovative interventions to improve medication adherence, introducing m-health programs, and decentralizing the management of chronic diseases are promising methods to reduce the burden of chronic disease management on such fragile health care systems.

          Related collections

          Author and article information

          Journal
          Can J Cardiol
          The Canadian journal of cardiology
          Elsevier BV
          1916-7075
          0828-282X
          Sep 2015
          : 31
          : 9
          Affiliations
          [1 ] Department of Community and Family Medicine, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: bowrya@smh.ca.
          [2 ] Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA; Department of Cardiology, Columbia University Medical Center, New York, New York, USA.
          [3 ] Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
          Article
          S0828-282X(15)00507-3
          10.1016/j.cjca.2015.06.028
          26321437
          09c66b3a-a3bc-4a5c-b194-47d609032cbb
          History

          Comments

          Comment on this article